MicroRNA-125a suppresses intestinal mucosal inflammation through targeting ETS-1 in patients with inflammatory bowel diseases
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 101, 109-120
Abstract
No abstract availableKeywords
Funding Information
- Youth Science Fund Project
This publication has 47 references indexed in Scilit:
- MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS)BMC Immunology, 2013
- Biogenesis, evolution and functional targets of microRNA-125aMolecular Genetics and Genomics, 2013
- Review of Ets1 structure, function, and roles in immunityCellular and Molecular Life Sciences, 2013
- Gene Deregulation and Chronic Activation in Natural Killer Cells Deficient in the Transcription Factor ETS1Immunity, 2012
- MicroRNA‐125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosusArthritis & Rheumatism, 2010
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated CancerCancer Cell, 2009
- Ets-1 is a negative regulator of Th17 differentiationJournal of Experimental Medicine, 2007
- Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell GenerationImmunity, 2007
- Ets-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responsesJournal of Experimental Medicine, 2005
- Functional Domains and DNA-binding Sequences of RFLAT-1/KLF13, a Krüppel-like Transcription Factor of Activated T LymphocytesJournal of Biological Chemistry, 2002